Gelatin Market Intelligence: Size, Share and Growth Outlook Through 2036
By Type, Nature, and End Use — Global Forecast to 2036
By Brevintel Editor•June 2026•PDF + Excel
Market Size (2025)
$3.5B
Market Forecast (2036)
$6.8B
CAGR (2025-2036)
6.2%
The gelatin market was valued at USD 3.5 billion in 2025. The market is set to reach USD 3.7 billion by 2026-end and grow at a CAGR of 6.2% between 2026-2036 to reach USD 6.8 billion by 2036. Type A will dominate with a 63.0% share, while Conventional will lead with a 91.0% share. Type B gelatin accounts for 58.0% of the type segment in 2026. The EU leads at 6.5% CAGR. Gelita AG holds the leading competitive position.
Key Market Trends & Insights
The gelatin market was valued at USD 3.5 billion in 2025 and is set to reach USD 3.7 billion by 2026-end.
The market is forecast to grow at a CAGR of 6.2% between 2026-2036 to reach USD 6.8 billion by 2036.
Type A will dominate with a 63.0% share, while Conventional will lead with a 91.0% share.
Type B gelatin accounts for 58.0% of the type segment in 2026, derived from alkaline-processed bovine hide and bone.
The EU leads at 6.5% CAGR, with South Korea at 6.3%.
The market is projected to create an absolute opportunity of USD 3.1 billion between 2026 and 2036.
Gelita AG holds the leading competitive position as the largest global gelatin producer.
Market Overview
Market Size and Outlook
The gelatin market was valued at USD 3.5 billion in 2025 and is set to reach USD 3.7 billion by 2026-end.
The market is set to grow at a CAGR of 6.2% between 2026-2036 to reach USD 6.8 billion by 2036.
Type A will dominate with a 63.0% share, while Conventional will lead with a 91.0% share.
The market is projected to create an absolute opportunity of USD 3.1 billion between 2026 and 2036.
Demand and Growth Drivers
Demand for gelatin is expanding as pharmaceutical capsule production, food and confectionery formulation, and nutraceutical supplement manufacturing sustain procurement for a versatile protein-based ingredient.
Type B gelatin accounts for 58.0% of the type segment in 2026, derived from alkaline-processed bovine hide and bone.
Pharmaceutical and nutraceutical applications are growing faster than food applications as capsule-based drug delivery and supplement encapsulation create structured demand.
Analyst Perspective
Brevintel analysis indicates gelatin producers that can maintain consistent pharmaceutical-grade quality, expand halal and kosher certified capacity, and develop specialized collagen peptide products are positioned to capture value growth through 2036.
The EU leads at 6.5% CAGR, supported by large-scale pharmaceutical capsule production, established confectionery manufacturing, and food ingredient quality standards.
Market Dynamics
Drivers, Restraints, and Opportunities
Pharmaceutical capsule production expansion is the primary demand driver for high-specification gelatin grades.
Marine gelatin from fish-derived collagen is the fastest-growing source category, targeting halal, kosher, and pescatarian market segments.
Collagen peptide derivatives for beauty and health supplements are expanding the addressable market.
Segmentation Analysis
Type and Nature Outlook
Type B gelatin holds 58.0% of the type segment in 2026, with bovine-sourced alkaline-processed gelatin leading demand for pharmaceutical capsule production and food gelling applications.
Type A gelatin from acid-processed porcine sources serves food gelling and confectionery applications.
Conventional gelatin dominates the nature segment, with halal and kosher certified grades serving specific religious dietary compliance markets.
End Use Outlook
Pharmaceutical end use represents a high-value application segment, where gelatin serves as the primary material for hard and soft capsule shells.
Food and confectionery applications including gummy candies, marshmallows, and dessert gelling represent the highest-volume end use.
Regional Outlook
EU and South Korea
The EU leads at 6.5% CAGR, supported by large-scale pharmaceutical manufacturing in Germany and France, established confectionery production, and food ingredient quality standards.
South Korea at 6.3% reflects pharmaceutical industry expansion, nutraceutical supplement growth, and food processing adoption of gelatin-based functional ingredients.
Competitive Landscape
Overview
Gelita AG holds the leading competitive position as the largest global gelatin producer with integrated collagen peptide portfolios serving pharmaceutical, food, and health nutrition markets.
Darling Ingredients Inc., Nitta Inc., Sterling Biotech Limited, and India Gelatine & Chemicals compete across bovine, porcine, and regional gelatin capacity.
Jellatech, Geltor, and CollPlant Biotechnologies compete in alternative and recombinant collagen platforms.
Key Players
Integrated Producers
Gelita AG
Darling Ingredients Inc.
Nitta Inc.
Sterling Biotech Limited
India Gelatine & Chemicals
Specialty Suppliers
Jellatech
Geltor
CollPlant Biotechnologies
Key Companies Covered
Gelita AG
Darling Ingredients Inc.
Nitta Inc.
Sterling Biotech Limited
India Gelatine & Chemicals
Jellatech
Geltor
CollPlant Biotechnologies
Table of Contents
The complete report includes additional chapters, data tables, and company profiles beyond this preview.
Key Takeaways
Market Size and CAGR
Top Growth Driver
Fastest Growing Segment
Leading Region
Key Companies
Emerging Opportunities
Executive Summary
Global Market Outlook
Demand-side Trends
Supply-side Trends
Technology Roadmap Analysis
Analysis and Recommendations
Analyst Perspective (What is happening? Why now? What should investors know?)
